PMID- 28248409
OWN - NLM
STAT- MEDLINE
DCOM- 20190501
LR  - 20220408
IS  - 1898-018X (Electronic)
IS  - 1898-018X (Linking)
VI  - 24
IP  - 6
DP  - 2017
TI  - Immediate and long-term outcomes of percutaneous transcatheter pulmonary valve 
      implantation.
PG  - 604-611
LID - 10.5603/CJ.a2017.0023 [doi]
AB  - BACKGROUND: Transcutaneous pulmonary valve replacement (TPVR) has become an 
      alternative to heart surgery for patients after previous right ventricular 
      outflow tract (RVOT) or pulmonary artery (PA) surgical interventions. The 
      objective was to present immediate and long-term outcomes of trans notcutaneous 
      pulmonary valve replacement. METHODS: Between 06/2009 and 06/2016, 46 patients 
      underwent TPVR. Initial diagnoses included tetralogy of Fallot, common arterial 
      trunk, transposition of great arteries post Rastelli correction, left ventricle 
      outflow obstruction after Ross operation, pulmonary atresia, and isolated 
      dysplastic pulmonary valve stenosis. Thirty eight (78%) patients had previously 
      implanted conduits in the pulmonary position, the rest had either RVOT patch 
      reconstruction (n = 6; 13%) or biological valve implantation (n = 2; 4%). They 
      presented primarily with pulmonary stenosis (n = 18; 39%) or regurgitation (n = 
      28; 60%). RESULTS: All procedures were successful - 44 Melody and 2 
      Edwards-Sapien valves were implanted. Before each procedure exclusion of 
      potential coronary compression and RVOT prestenting was performed. Significant 
      RVOT systolic gradient reduction (from 35.3 +/- 19.5 to 13.5 +/- 7.1 mm Hg; p < 
      0.001) and decrease of right to left ventricle systolic pressure ratio from 0.58 
      +/- 0.18 to mean 0.37 +/- 0.1 (p < 0.001) was achieved. Also, in every patient 
      PA-RVOT competence was restored, with minor in notcompetence in only a few patients. 
      Post procedure follow-up ranged from 2 to 86 (mean 35.2) months. Follow-up 
      fluoroscopy or chest X-ray revealed 6 stent fractures (2 stent defragmentation - 
      with only 1 significant valve stenosis). CONCLUSIONS: Transcutaneous pulmonary 
      valve replacement is a safe procedure with encouraging results, it also enables 
      deferring surgical reintervention in the majority of patients.
FAU - Fiszer, Roland
AU  - Fiszer R
AD  - Silesian Center for Heart Diseases Department of Congenital Heart Diseases and 
      Pediatric Cardiology. rfiszer@gumed.edu.pl.
FAU - Dryzek, Pawel
AU  - Dryzek P
FAU - Szkutnik, Malgorzata
AU  - Szkutnik M
FAU - Goreczny, Sebastian
AU  - Goreczny S
FAU - Krawczuk, Alexandra
AU  - Krawczuk A
FAU - Moll, Jadwiga
AU  - Moll J
FAU - Moszura, Tomasz
AU  - Moszura T
FAU - Pawlak, Szymon
AU  - Pawlak S
FAU - Bialkowski, Jacek
AU  - Bialkowski J
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
DEP - 20170301
PL  - Poland
TA  - Cardiol J
JT  - Cardiology journal
JID - 101392712
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Cardiac Catheterization/*methods
MH  - Child, Preschool
MH  - Female
MH  - Fluoroscopy
MH  - Follow-Up Studies
MH  - Heart Valve Prosthesis Implantation/*methods
MH  - Humans
MH  - Male
MH  - Prosthesis Design
MH  - Pulmonary Valve/diagnostic imaging/*surgery
MH  - Pulmonary Valve Insufficiency/diagnosis/*surgery
MH  - Pulmonary Valve Stenosis/diagnosis/*surgery
MH  - Retrospective Studies
MH  - Time Factors
MH  - Treatment Outcome
OTO - NOTNLM
OT  - congenital heart disease
OT  - pulmonary valve
OT  - transcatheter valve implantation
EDAT- 2017/03/02 06:00
MHDA- 2019/05/02 06:00
CRDT- 2017/03/02 06:00
PHST- 2016/09/27 00:00 [received]
PHST- 2017/01/05 00:00 [accepted]
PHST- 2017/12/28 00:00 [revised]
PHST- 2017/03/02 06:00 [pubmed]
PHST- 2019/05/02 06:00 [medline]
PHST- 2017/03/02 06:00 [entrez]
AID - VM/OJS/J/48959 [pii]
AID - 10.5603/CJ.a2017.0023 [doi]
PST - ppublish
SO  - Cardiol J. 2017;24(6):604-611. doi: 10.5603/CJ.a2017.0023. Epub 2017 Mar 1.